New Approaches to Treating Heart Failure
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker's Bureau - Sequana Medical AV; Genomics plc; Cardiol Therapeutics Inc; American Board of Internal Medicine; Springer Nature; Boston Scientific Corporation; WhiteSwell; Zehna Therapeutics LLC; CardiaTec Biosciences; Intellia Therapeutics; Renovacor; Kiniksa Pharmaceuticals
- Grant Support/Research Contract - Alnylam Pharmaceuticals; Pfizer Inc / Array Biopharma; SalubrisBio; Bristol-Myers Squibb; Pfizer Inc; BioCardia Inc; Cordio; Applied Therapeutics; Cardurion Pharmaceuticals; Tenaya
- Honorarium - Belvoir Media Group